These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29082571)

  • 21. Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.
    Braida D; Donzelli A; Martucci R; Capurro V; Busnelli M; Chini B; Sala M
    Psychopharmacology (Berl); 2012 Mar; 220(2):319-30. PubMed ID: 21956239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains.
    Taylor JH; McCann KE; Ross AP; Albers HE
    J Neuroendocrinol; 2020 Jul; 32(7):e12882. PubMed ID: 32662552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V
    Taveau C; Chollet C; Bichet DG; Velho G; Guillon G; Corbani M; Roussel R; Bankir L; Melander O; Bouby N
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E127-E135. PubMed ID: 27998960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central oxytocin signaling mediates the central orexin-induced visceral antinociception through the opioid system in conscious rats.
    Okumura T; Nozu T; Kumei S; Ohhira M
    Physiol Behav; 2019 Jan; 198():96-101. PubMed ID: 30342057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral oxytocin receptors inhibit the nociceptive input signal to spinal dorsal horn wide-dynamic-range neurons.
    González-Hernández A; Manzano-García A; Martínez-Lorenzana G; Tello-García IA; Carranza M; Arámburo C; Condés-Lara M
    Pain; 2017 Nov; 158(11):2117-2128. PubMed ID: 28731982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin and vasopressin modulate the social response to threat: a preclinical study.
    Bowen MT; McGregor IS
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1621-33. PubMed ID: 24807123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
    Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G
    Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
    Tahara A; Tsukada J; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M
    Pharmacol Res; 2005 Mar; 51(3):275-81. PubMed ID: 15661579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.
    Brouard R; Laporte V; Serradeil Le Gal C; Pignol R; Jang H; Donat F; Lockwood G; Fournie D; Dreux F
    Adv Exp Med Biol; 1998; 449():455-65. PubMed ID: 10026839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronic social defeat on behavioral and neural correlates of sociality: Vasopressin, oxytocin and the vasopressinergic V1b receptor.
    Litvin Y; Murakami G; Pfaff DW
    Physiol Behav; 2011 Jun; 103(3-4):393-403. PubMed ID: 21397619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of arginine vasopressin receptor 1a facilitates the induction of long-term potentiation in the accessory olfactory bulb of male mice.
    Namba T; Taniguchi M; Murata Y; Tong J; Wang Y; Okutani F; Yamaguchi M; Kaba H
    Neurosci Lett; 2016 Nov; 634():107-113. PubMed ID: 27697521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.
    Busnelli M; Bulgheroni E; Manning M; Kleinau G; Chini B
    J Pharmacol Exp Ther; 2013 Aug; 346(2):318-27. PubMed ID: 23723434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
    Griffante C; Green A; Curcuruto O; Haslam CP; Dickinson BA; Arban R
    Br J Pharmacol; 2005 Nov; 146(5):744-51. PubMed ID: 16158071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxytocin and vasopressin modulation of social anxiety following adolescent intermittent ethanol exposure.
    Dannenhoffer CA; Kim EU; Saalfield J; Werner DF; Varlinskaya EI; Spear LP
    Psychopharmacology (Berl); 2018 Oct; 235(10):3065-3077. PubMed ID: 30141056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
    Krieg SM; Sonanini S; Plesnila N; Trabold R
    J Neurotrauma; 2015 Feb; 32(4):221-7. PubMed ID: 25111427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.